Algernon Pharmaceuticals Inc (AGN.CX)
0.14
0.00 (0.00%)
CAD |
CNSX |
May 16, 16:00
Algernon Pharmaceuticals Net Income (TTM): -6.734M for Nov. 30, 2022
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| November 30, 2022 | -6.734M |
| August 31, 2022 | -6.054M |
| May 31, 2022 | -4.077M |
| February 28, 2022 | -4.951M |
| November 30, 2021 | -5.500M |
| August 31, 2021 | -7.734M |
| May 31, 2021 | -10.48M |
| February 28, 2021 | -13.40M |
| November 30, 2020 | -11.80M |
| August 31, 2020 | -8.536M |
| May 31, 2020 | -5.973M |
| February 29, 2020 | -1.911M |
| November 30, 2019 | -1.568M |
| August 31, 2019 | -1.896M |
| Date | Value |
|---|---|
| May 31, 2019 | -1.662M |
| February 28, 2019 | -1.525M |
| November 30, 2018 | -1.238M |
| August 31, 2018 | -0.9376M |
| May 31, 2018 | -1.038M |
| February 28, 2018 | -1.410M |
| November 30, 2017 | -1.577M |
| August 31, 2017 | -1.891M |
| May 31, 2017 | -1.875M |
| February 28, 2017 | -1.575M |
| November 30, 2016 | -3.274M |
| August 31, 2016 | -6.877M |
| May 31, 2016 | -6.804M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-13.40M
Minimum
Feb 2021
-1.568M
Maximum
Nov 2019
-6.152M
Average
-5.973M
Median
May 2020
Net Income (TTM) Benchmarks
| Biocure Technology Inc | -1.814M |
| Core One Labs Inc | -6.004M |
| Nova Mentis Life Science Corp | -2.184M |
| Nanosphere Health Sciences Inc | -0.3079M |
| Lobe Sciences Ltd | -4.183M |